Clinical Trials Directory

Trials / Conditions / Osteosarcoma Recurrent

Osteosarcoma Recurrent

8 registered clinical trials studyying Osteosarcoma Recurrent — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingTegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
NCT07144254
Emory UniversityPhase 1
RecruitingDFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma
NCT06892678
Montefiore Medical CenterPhase 1 / Phase 2
RecruitingStudy in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for
NCT06607692
Fundación de investigación HMPhase 1 / Phase 2
Active Not RecruitingSARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma
NCT04803877
Sarcoma Alliance for Research through CollaborationPhase 2
Active Not RecruitingOlaparib With Ceralasertib in Recurrent Osteosarcoma
NCT04417062
Dana-Farber Cancer InstitutePhase 2
CompletedAn Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer
NCT04651569
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna—
CompletedStudy of Effectiveness of GEMDOX in Relapsed Osteosarcoma
NCT04651179
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna—
Active Not RecruitingNivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
NCT03628209
H. Lee Moffitt Cancer Center and Research InstitutePhase 1